| Disease | ADMINISTRATION OF A 180 MG DOSE OF PSE INCREASED MAX. TORQUE, PROUDCED IN AN ISOMETRIC KNEE EXTENSION AND PRODUCED AN IMPROVEMENT IN PEAK POWER DUING MAXIMAL CYCLE PERFORMANCE, AS WELL AS IMPROVING LUNG FUNCTION.
RESP.) ALTHOUGH THE FEV1/FVC RATION WAS NOT ALTERED. HEART RATE WAS SIGNIFICANTLY ELEVATED BY THE INGESITON OF PSE IMMEDIATELY FOLLOWING THE 30 S CYCLE SPRINT (P<0.10) HOWEVER, LACTATE CONCN. WAS NOT ALTERED BY THE INGESTION OF PSE. THE
WHEN PSE WAS NOT INGESTED. BENCH PRESS TASKS AND TOTAL WORK DURING THE CYCLE TEST WERE NOT AFFECTED BY THE INGESTION OF PSE. LUNG FUNCTIONS WAS ALTERED FOLLOWING INGESTION PSE (P<0.05) WITH FEV1 AND FVC SIGNIFICANTLY INCREASED (P>0.02, P<0.01,
"ALL-BUT" 30 S CYCLE TEST WAS 1262.5+48.5 W (PSE) AND 1228.4+47.1 W (PLACEBO) (P<0.01, P<0.03, RSP.) SUBJECTS WERE ESTD. TO BE PRODUCING 96.9+2.4% OF THEIR MAXIMAL POSSIBLE ISOMETRIC LEG EXTENSION FORCE AFTER PSE INGESTION, BUT ONLY 95.3+2.4%
A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY IN 22 HEALTHY MALE ATHELETES. MAXIMUM TORQUE (MEAN + S.D., N=22) PRODUCED IN AN ISOMETRIC KNEE EXTENSION EXERCISE WS 321.1+62.0 NM (PSE) AND 295.7+72.4 NM (PLACEBO), AND PEAK POWER OBTAINED ON THE |